Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease

Table 2 Primary outcome: bowel cleanliness

	Numbers of studies	ITT patients	OR (95%CI)	Heterogeneity P value	I2
Primary outcome
Bowel cleanliness	2	325	1.19 (0.52-2.71)	0.27	19%
Secondary outcome
Willingness to repeat	2	320	5.11 (1.31-20.00)	0.03	78%
Procedure related outcome
Rates of cecal intubation	2	320	0.91 (0.32-2.53)	0.54	0%
Mayo endoscopic score = 0	2	320	1.09 (0.69-1.70)	0.38	0%
Mayo endoscopic score = 1	2	320	0.84 (0.54-1.33)	0.61	0%
Mayo endoscopic score = 2	1	109	1.17 (0.46-3.00)	-	-
Mayo endoscopic score = 3	2	320	2.89 (0.30-28.24)	1.00	0%
Side effects or complications
Flare of disease	1	109	0.62 (0.10-3.85)	-	-
Increase SCAII score	1	109	1.14 (0.47-2.75)	-	-
Dizziness	1	109	1.44 (0.23-9.00)	-	-
Abdominal pain/cramps	1	109	0.30 (0.03-3.01)	-	-
Bloating	1	109	0.72 (0.26-1.98)	-	-
Nausea	1	109	0.39 (0.16-0.94)	-	-
Vomiting	1	109	0.55 (0.17-1.81)	-	-
Insomnia	1	109	1.72 (0.70-4.23)	-	-

ITT: Intention-to-treat.